Microbial Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028
Global Microbial Products Market: Overview
Industrial microbiology encompasses the use of microorganisms and their metabolites for a wide variety of industrial products. Products derived from microbial products include a variety of beverages, food additives, healthcare products, and biofuels. Microbial products have been extensively utilized in fermentation processes for the commercial production of a range of enzymes such as cellulose, amylase, protease, lipase, streptokinase, and pectinase, and various types of antibiotics in the healthcare industries. This has given rise to a distinct global microbial products market. In addition, microbial products have been utilized for antibiotics, nutrients such as amino acids, vitamins, and organic acids, chemotherapeutic agents, vaccines. Key categories of microbial products are bacteria, fungi, protozoa, viruses, and yeasts. Various types of bacteria and fungi have emerged as good candidates in control mechanism of various plant diseases in the agriculture industry, world over.
Global Microbial Products Market: Key Trends
The rising relevance of microbial products in the production of enzymes for end-use industries such as paper, leather, and food preservation is propelling the growth of the market. Growing use of microbial products in producing healthcare and agriculture products with the help of genetic engineering methods is also boosting the global microbial products market. The market’s growth has been receiving constant, large impetus from recent advances in fermentation technology. The advent of genetic recombinant technology has enabled industry players produce more environmental-friendly and cost-effective products. Rising demand for microbial products for clinical diagnostics products is a key factor boosting the global microbial products market.
Global Microbial Products Market: Market Potential
Recent research have focused on manipulating microbiome to generate higher-value chemical products. This has paved way to a wide range of preferred products. A recent study by a team of researchers at University of Wisconsin-Madison analyzed the potential of a mixed microbial community. They found using a bioreactor that their constitution and metabolic activity hold enormous potential in generating industrial products of vast commercial significance. Applying thermodynamic analysis, they found that leftovers of lignocellulosic ethanol production improved the production of medium-chain fatty acids. These acids are potential source of industrial chemicals and pharmaceuticals in the microbial products market. Research sheds light on the community of microbes that make these materials useful in biofuel production. However, whether such a community of microorganisms needs genetic engineering approach is open to debate and may influence the future direction of research. Furthermore, recent advances in biotechnology have expanded the prospects of engineering microorganisms, creating new, exciting avenues in the microbial products market.
Global Microbial Products Market: Regional Outlook
On the regional front, developed countries, notably the U.S., has been increasingly lucrative markets for microbial products. Rising production and consumption of microbial products and rapidly rising expenditure on utilizing microbes for healthcare products in these regions are generating substantial revenue prospects. For instance, in the U.S., sizeable investments being made in industrial microbiology production methods to generate an array of useful health-related products for humans and animals is creating new avenues in the microbial products market in this region. Rising per capita expenditure, coupled with favorable reimbursement scenarios, is fueling the strides in industrial microbiology.
Global Microbial Products Market: Competitive Landscape
The competitive landscape of the global microbial products is expected to feature an increasingly fragmented landscape. This has put substantial pressure on profit of manufacturers and producers in the global microbial products market. Some of the players aiming to hold sizeable shares in the global market are Novartis AG, Sanofi S.A, bioMérieux SA, Pfizer Inc., GlaxoSmithKline plc, Valent BioSciences Corp., and Merck & Co., Inc.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report